Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cell Signaling Technology Inc.

www.cellsignal.com

Latest From Zynaxis Inc.

Spinning off Small Companies

The post-merger cutting room floor creates a great source of new companies and products--it’s good asset management for Big Pharma, and it’s good for medical entrepreneurs. But culturally and structurally, most large companies just can’t go along with the business logic of spin-offs. Technology that does get spun off is most often completely peripheral to the parent’s business--e.g., in vitro diagnostic applications or software and equipment systems from a drug company.
Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cell Signaling Technology Inc.
  • Senior Management
  • Michael J Comb, PhD, Pres. & CEO
    Fenel Eloi, CFO & COO
    Roberto Polakiewicz , PhD, CSO
  • Contact Info
  • Cell Signaling Technology Inc.
    Phone: (978) 867-2300
    3 Trask Ln.
    Danvers, MA 01923
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register